Please Wait.....
Report
Ankylosing Spondylitis Treatment Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
Market Report I 2023-01-23 I 120 Pages I Mordor Intelligence
The Global Ankylosing Spondylitis Market is expected to grow at a CAGR of 6.4% during the forecast period (2023 - 2028).
The COVID-19 pandemic impacted the ankylosing spondylitis market due to disruptions in various clinical studies and supply chains. Ankylosing spondylitis drug suppliers faced several challenges due to travel restrictions, business closures, stay-at-home protocols, and trade bans during the pandemic. Additionally, precautionary measures taken by governments like social distancing and restrictions have severely disrupted the patient's treatments in the hospital. The pandemic and emergence of variants continue to cause, concern, and sudden and drastic downturn in the economic activity of several countries. This has expected to decline in the market growth during the pandemic.
The growth of the global?ankylosing spondylitis drug market is majorly driven by an increase in the prevalence rate of the target disease. According to the article published by the Scandinavian Journal of Rheumatology in 2022, titled "Psoriatic arthritis, axial spondylitis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents", the prevalence rate of spondylitis was 0.41%. Furthermore, the recent advancement in therapy, growing awareness about diagnostics and treatments for the disease, development of effective drugs are the major contributors to the growth of the market. Additionally, government initiatives and advanced healthcare infrastructure are expected to propel market growth over the forecast period.
Many companies are investing on large scale in research and development of ankylosing spondylitis drugs and therapies. Moreover, they are collaborating and adopting merger and acquisitions strategies for getting a stronger investment for the drugs. Thus, the rise in R&D investment is positively influencing the market growth. For instance, Bowie Shenqi Pill (Shanghai University of Traditional Chinese Medicine), Bimekizumab (UCB Biopharma), and Namilumab (Takeda Pharmaceuticals International GmbH) drugs are under development phase. This is expected to propel the market growth over the forecast period.
Due to a lack of awarfeness regarding ankylosing spondylitis in many nations, many individuals do not seek medical care and instead treat it as a normal ache. This scenario is particularly common in developing countries, which results in restraining the growth of the market.
Ankylosing Spondylitis Treatment Market Trends
Medication Segment is Expected to Hold a Large Share in the Market
Medication dominated the market in 2021 and is expected to grow during the forecast period due to the rise in ankylosing spondylitis patients and an increase in the adoption of medications for the treatment. Medication is focused on reducing the discomfort caused due to ankylosing spondylitis. Nonsteroidal anti-inflammatory drugs such as ibuprofen and naproxen, disease-modifying antirheumatic drugs such as methotrexate, and biologics including anti-TNF, and anti-IL7 drugs are some of the medications used to reduce pain and swelling.
Furthermore, new product launches are likely to fuel the treatment market, as they are used as the first line of treatment. For instance, in December 2021, Pfizer received approval from the United States Food and Drug Administration (FDA) for tofacitinib, known as Xeljanz or Xeljanz XR, a new medication to treat ankylosing spondylitis (AS) and other disorders like rheumatoid arthritis, juvenile Idiopathic Arthritis. Additionally, in October 2020, Cadila Pharmaceuticals launched the biosimilar of adalimumab, Cadalimab in India which is used to treat psoriatic arthritis, rheumatoid arthritis, psoriasis, and ankylosing spondylitis.
North America Dominates the Market and is Expected to do the Same Over the Forecast Period
North America is anticipated to dominate the ankylosing spondylitis treatment market due to the rise in incidences and prevalence of target diseases, the presence of key players, well-established infrastructure in the region, and?the increasing adoption of the latest technologies?for better diagnosis options. As per the statistics published by The National Center for Biotechnology Information, in 2021, the prevalence of ankylosing spondylitis is approximately 5% to 6% in people who are HLA-B27 positive.
In addition, the approvals of drugs in the region for the treatment of ankylosing spondylitis are further boosting the growth of the market. for instance, In Feb 2020, Taltz (ixekizumab) received approval from Health Canada for treating adults with ankylosing spondylitis who failed to respond to other treatments. Furthermore, rapid adoption of new therapies and treatment options, raising awareness, and high healthcare expenditure in the region are expected to boost the market share of the region in the industry.
Ankylosing Spondylitis Treatment Market Competitor Analysis
The global ankylosing spondylitis treatment market is moderately competitive with several players across the globe. The majority of the key player is involved in the research and manufacturing of ankylosing spondylitis?therapy drugs. These market players have gained a high market share and offer a wide range of products with an extensive distribution system across the world. Some of the major key players are Novartis, Amgen, Boehringer Ingelheim International GmbH, UCB Biopharma, and AbbVie.
Additional Benefits:
The market estimate (ME) sheet in Excel format
3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Target Diseases
4.2.2 Development and Commercialization of effective Product
4.3 Market Restraints
4.3.1 Huge cost of treatment
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value-USD million)
5.1 By Treatment Types
5.1.1 Medication
5.1.1.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
5.1.1.2 TNF Inhibitors
5.1.1.3 IL-17 Inhibitors
5.1.1.4 Others
5.1.2 Therapy
5.1.3 Surgery
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Novartis AG
6.1.2 AbbVie Inc.
6.1.3 UCB
6.1.4 Amgen Inc.
6.1.5 Boehringer Ingelheim International GmbH
6.1.6 Celltrion Healthcare
6.1.7 Reliance Life Sciences
6.1.8 Janssen CarePath
6.1.9 Sandoz International GmbH
6.1.10 Pfizer
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security